Bausch Health Companies (BHC) EBT Margin (2009 - 2026)
Bausch Health Companies' (BHC) quarterly EBT Margin came in at 12.2% in Q2 2026, up 667.0% year-over-year from 1.59% in Q2 2025, and up 122.75% quarter-over-quarter from 53.65% in Q1 2026.
Powered by 
Analysis
Bausch Health Companies (BHC) EBT Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed EBT Margin across 18 years of filings, most recently posting 12.2% for Q2 2026.
- In Q2 2026, EBT Margin rose 667.0% year-over-year to 12.2%; the TTM figure through Jun 2026 stood at 6.74% (down 960.0% YoY), while the FY2025 annual figure was 3.57%, up 184.0% from the prior year.
- EBT Margin came in at 12.2% for Q2 2026 at Bausch Health Companies, up from 53.65% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 21.46% in Q3 2022 to a low of 53.65% in Q1 2026.
- Average EBT Margin over 5 years is 2.53%, with a median of 0.56% recorded in 2023.
- Year-over-year, EBT Margin jumped 2535 bps in 2022 and sank 5156 bps in 2026.
- Over 5 years, EBT Margin stood at 16.28% in 2022, then jumped by 98 bps to 0.29% in 2023, then surged by 2910 bps to 8.17% in 2024, then tumbled by 75 bps to 2.0% in 2025, then jumped by 509 bps to 12.2% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 12.2% in Q2 2026, 53.65% in Q1 2026, and 2.0% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -10.99% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -1.70% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.85% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 8.92% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 12.20% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -121.92% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 13.94% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 20.96% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 11.27% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.20% |
| Mar 31, 2026 | -53.65% |
| Dec 31, 2025 | 2.00% |
| Sep 30, 2025 | 8.13% |
| Jun 30, 2025 | 5.53% |
| Mar 31, 2025 | -2.08% |
| Dec 31, 2024 | 8.17% |
| Sep 30, 2024 | -0.84% |
| Jun 30, 2024 | 2.00% |
| Mar 31, 2024 | -3.20% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -14.57% |
| Jun 30, 2023 | 3.65% |
| Mar 31, 2023 | -7.00% |
| Dec 31, 2022 | -16.28% |
| Sep 30, 2022 | 21.46% |
| Jun 30, 2022 | -6.56% |
| Mar 31, 2022 | -4.28% |
| Dec 31, 2021 | 0.96% |
| Sep 30, 2021 | 10.23% |